Keensight Capital
Also known as Keensight
Paris European growth-buyout firm investing €10M–€800M as minority or majority partner in profitable technology and healthcare companies; €8bn+ AUM (Dec 2025).
- HEADQUARTERS
- Paris, France
- FOUNDED
- —
- AUM
- €8B (2025)
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 9 people
FOCUS
- STAGES
- GrowthBuyout
- ASSET MIX
- Private equity
- GEOGRAPHY
- Europe
WHAT IT IS
Private Equity Fund. A fund manager investing limited-partner capital into mature private companies.
ABOUT
Keensight Capital is a Paris-based European growth buyout investor specialised in technology and healthcare. It backs fast-growing, profitable companies headquartered in Europe with €10M–€400M of revenue, financing organic growth and acquisitions or providing liquidity to shareholders, with tickets of €10M–€800M with or without leverage, as a minority or majority partner. It reports more than €8bn of assets under management at 31 December 2025 and a track record of 51 exits from 88 investments. Its Keensight Performance team provides operational support to portfolio companies.
INVESTMENT THESIS
Fast-growing, profitable Technology and Healthcare companies headquartered in Europe with €10M–€400M revenue and international scale; €10M–€800M tickets with or without leverage, minority or majority; value creation through pricing, sales excellence, M&A, supply chain and internationalisation.
PORTFOLIO (12)
- NomiosNOTABLESoftware & SaaS
- Bedfont ScientificHealthTech · since 2025
- Decision FocusSoftware & SaaS · since 2025
- Isto BiologicsBiotech & Life Sciences · since 2025
- UVE SolutionsSoftware & SaaS · since 2025
- Dimo MaintSoftware & SaaS · since 2025
- ACTICOFintech · since 2025
- MetaComplianceSoftware & SaaS
- Plat4mationSoftware & SaaS
- SogelinkSoftware & SaaS
- InkeBiotech & Life Sciences
- smartTrade TechnologiesFintech · Exited
TEAM
- Jean-Michel BeghinManaging Partner · source
- Philippe CrochetManaging Partner · source
- Arnaud CohenPartner and Chief Operating Officer · source
- Charles CoxPartner and Global Head of Investor Relations · source
- Ana Alvarez GrullonPartner, Head of ESG and Sustainability · source
- Charles BonnassieuxPartner · source
- Jean-Christophe CiniPartner · source
- Arjan HanninkPartner · source
- Stephane PratsPartner, Head of Keensight Performance · source
LINKS
FAQ
Keensight Capital is a private equity fund based in Paris, France.
Yes. Keensight Capital invests directly in private companies.
Keensight Capital invests at Growth and Buyout stages in Software & SaaS, HealthTech and Biotech & Life Sciences.
Keensight Capital's stated ticket size is €10M–€800M.
Key people at Keensight Capital include Jean-Michel Beghin (Managing Partner), Philippe Crochet (Managing Partner), Arnaud Cohen (Partner and Chief Operating Officer) and Charles Cox (Partner and Global Head of Investor Relations).
Keensight Capital's investments include Nomios, Bedfont Scientific, Decision Focus, Isto Biologics, UVE Solutions, Dimo Maint, ACTICO and MetaCompliance, among others.
The most recent publicly reported investment by Keensight Capital is Bedfont Scientific (Majority stake (growth buyout)), announced in Oct 2025.
Yes. Keensight Capital manages capital from outside investors.